Please provide your email address to receive an email when new articles are posted on . High FeNO levels indicate exacerbation and lung function risks. Most patients with high FeNO levels also had ...

Zunveyl is supplied as 5mg, 10mg, and 15mg delayed-release tablets, which can be taken with or without food. Zunveyl ® (benzgalantamine) is now available for the treatment of mild to moderate dementia ...

More patients in FMD group met primary outcome of clinical response and prespecified secondary outcome of clinical remission.

Efinaconazole 10% solution was found to be a safe and effective treatment of chronic fungal nail infections among patients with skin of color, according to a study published in the Journal of Drugs in ...

"What should I eat?" is perhaps the most common question patients with inflammatory bowel disease ask their doctors. It's notoriously difficult to answer. There have been few large studies of dietary ...

Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of symptoms, results of the randomized controlled ACTIV-6 trial showed. After receiving ...

Apple really pulled off a great feat. You can now test your hearing with your AirPods Pro 2 and an iPhone running iOS 18. It’s a groundbreaking feature, FDA-approved and perfect for catching mild to ...

The effectiveness of repurposed medications for treating COVID-19 remains a critical area of investigation. A new analysis found that higher-dose fluvoxamine (Luvox), an antidepressant with ...

A mindfulness-based cognitive therapy self-help (MBCT-SH) intervention in which patients were supported by a trained practitioner led to better clinical outcomes at lower cost than ...

PURCHASE, N.Y., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs ...